Matches in Nanopublications for { ?s ?p "[Here, we show that treatment of NRAS-mutant melanoma cell lines with the MEK inhibitors AZD6244 or trametinib resulted in a rebound activation of phospho-ERK (pERK).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[Here, we show that treatment of NRAS-mutant melanoma cell lines with the MEK inhibitors AZD6244 or trametinib resulted in a rebound activation of phospho-ERK (pERK).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_assertion description "[Here, we show that treatment of NRAS-mutant melanoma cell lines with the MEK inhibitors AZD6244 or trametinib resulted in a rebound activation of phospho-ERK (pERK).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211330.RA523piO9zZM-SWFNnNQEc2u4d6esRM8_Q9gPltyjWNIQ130_provenance.